Prevalence of Germline BRCA1 and BRCA2 Deleterious Mutations in Brazilian Patients with High-Risk of Breast and Ovarian Cancer.

被引：0
|
作者：
Diz, M. D. P. E. [1 ]
Escobar, K. A. [1 ]
Guindalini, R. S. C. [1 ]
Pasini, F. S. [1 ]
Snitkoyiski, M. L. [1 ]
Maistro, S. [1 ]
Hoff, P. M. G. [1 ]
Federico, M. H. H. [1 ]
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-13-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-13-07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [42] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    M J L Ligtenberg
    F B L Hogervorst
    H W Willems
    P J W Arts
    G Brink
    S Hageman
    E A J Bosgoed
    E Van der Looij
    M A Rookus
    P Devilee
    E M A W Vos
    G Wigbout
    P M Struycken
    F H Menko
    E J Th Rutgers
    E H Hoefsloot
    E C M Mariman
    H G Brunner
    L J Van’t Veer
    British Journal of Cancer, 1999, 79 : 1475 - 1478
  • [43] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    Ligtenberg, MJL
    Hogervorst, FBL
    Willems, HW
    Arts, PJW
    Brink, G
    Hageman, S
    Bosgoed, EAJ
    Van der Looij, E
    Rookus, MA
    Devilee, P
    Vos, EMAW
    Wigbout, G
    Struycken, PM
    Menko, FH
    Rutgers, EJT
    Hoefsloot, EH
    Mariman, ECM
    Brunner, HG
    Van't Veer, LJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1475 - 1478
  • [44] PARP inhibition with BMN 673 in ovarian and breast cancer patients with deleterious mutations of BRCA1 and BRCA2
    Ramanathan, R.
    Wainberg, Z.
    Mina, L.
    Byers, L.
    Chugh, R.
    Zhang, C.
    Henshaw, J.
    Dorr, A.
    de Bono, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S13 - S13
  • [45] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Zeinali, Sirous
    FAMILIAL CANCER, 2012, 11 (01) : 57 - 67
  • [46] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Zhang, Yinmei
    Wu, Heming
    Gan, Caiyan
    Rao, Hui
    Wang, Qiuming
    Guo, Xueming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [47] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Fatemeh Keshavarzi
    Gholam Reza Javadi
    Sirous Zeinali
    Familial Cancer, 2012, 11 : 57 - 67
  • [48] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Yinmei Zhang
    Heming Wu
    Caiyan Gan
    Hui Rao
    Qiuming Wang
    Xueming Guo
    BMC Medical Genomics, 17
  • [49] Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients
    Ahn, SH
    Hwang, UK
    Kwak, BS
    Yoon, HS
    Ku, BK
    Kang, HJ
    Kim, JS
    Ko, BK
    Ko, CD
    Yoon, KS
    Cho, DY
    Kim, JS
    Son, BH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (02) : 269 - 274
  • [50] The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population
    Song, Honglin
    Cicek, Mine S.
    Dicks, Ed
    Harrington, Patricia
    Ramus, Susan J.
    Cunningham, Julie M.
    Fridley, Brooke L.
    Tyrer, Jonathan P.
    Alsop, Jennifer
    Jimenez-Linan, Mercedes
    Gayther, Simon A.
    Goode, Ellen L.
    Pharoah, Paul D. P.
    HUMAN MOLECULAR GENETICS, 2014, 23 (17) : 4703 - 4709
12345